Skip to main content

Advertisement

Log in

Catheter-related infections in chronic hemodialysis: a clinical and economic perspective

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Central venous catheters emerged as a major risk factor for infectious complications in hemodialysis (HD) patients. We aimed to assess the incidence of bacteremia in catheter-dependent HD patients and to characterize its clinical and economic impact.

Methods

We retrospectively collected clinical data and healthcare costs from 15 months for 75 admitted catheter-dependent HD patients, to document the type of bacteremia (complicated or not), pathogen and inflammation.

Results

Bacteremia (97 % with Staphylococcus aureus, 33 % methicillin-resistant) was present in 51 % patients, with an overall infections incidence of 5.79 per 1,000 catheter-days. Metastatic complications occurred in 21 % of bacteremic patients and were associated with higher mortality (38 vs. 4 %; p = 0.001). Although, in patients starting dialysis on catheter (41 %) as compared to those using catheter as bridge angioaccess, inflammation (higher C-reactive protein; p = 0.006) and anemia (lower Hb; p = 0.008) were more pronounced, bacteremia occurred in a lower proportion (32 vs. 64 %, p = 0.007). The total medical costs were 47 % higher in patients with complicated bacteremia than in those without bacteremia (p = 0.008) and 45 % higher in patients starting HD on catheter than in those using catheter as bridge angioaccess (p = 0.002).

Conclusions

Despite the limitations resulting from retrospective cross-sectional single-center design, our study suggests that patients already on HD who required catheters as bridge angioaccess were more prone to bacteremia. This highlights the importance of close angioaccess monitoring to avoid unnecessary catheter usage. A similar increase in costs when initiating dialysis on catheter as in case of complicated bacteremia strongly supports the initial placement of a native arteriovenous fistula.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bloembergen WE, Port FK (1996) Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 3:201–207

    PubMed  CAS  Google Scholar 

  2. Nassar GM, Ayus J (2001) Infectious complications of the hemodialysis access. Kydney Int 60:1–13

    Article  CAS  Google Scholar 

  3. Katneni R, Hedayati S (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3(5):256–266

    Article  PubMed  Google Scholar 

  4. Taylor G, Gravel D, Johnston L (2004) Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32:155–160

    Article  PubMed  Google Scholar 

  5. Vandecasteele SJ, Boelaert JR, De Vriese AS (2009) Staphylococcus aureus infection in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol 4:1388–1400

    Google Scholar 

  6. Lemaire X, Morena M, Leary-Moragues H et al (2009) Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 28:21–28

    Article  PubMed  Google Scholar 

  7. Allon M (2004) Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44:779–791

    PubMed  Google Scholar 

  8. Teehan GS, Ruthazer R, Balakrishnan VS, Snydman D, Jaber BL (2004) Iron storage indices and risk of bacterial infections in hemodialysis patients. Hemodial Int 8:226–232

    Article  PubMed  Google Scholar 

  9. Ramanathan V, Chiu EJ, Thomas JT et al (2007) Healthcare costs associated with hemodialysis catheter related infections: a single center experience. Infect Control Hosp Epidemiol 28:606–609

    Article  PubMed  Google Scholar 

  10. Nissenson AR, Dylan ML, Griffiths RI et al (2005) Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 46:301–308

    Article  PubMed  Google Scholar 

  11. Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539

    Article  PubMed  Google Scholar 

  12. Danese MD, Griffiths R, Dylan M, Yu HT, Dubois R, Nissenson R (2006) Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 10:56–62

    Article  PubMed  Google Scholar 

  13. Al-Solaiman Y, Estrada E, Allon M (2011) The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol 6:2247–2252

    Article  PubMed  Google Scholar 

  14. Poole CV, Carlton D, Bimbo L, Allon M (2004) Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19:1237–1244

    Article  PubMed  CAS  Google Scholar 

  15. Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD (2009) Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 30:4–8

    Article  PubMed  Google Scholar 

  16. Lederer SR, Riedelsdorf G, Schiffl H (2007) Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among out clinic haemodialysis patients. Eur J Med Res 12:284–288

    PubMed  CAS  Google Scholar 

  17. Inrig JK, Reed S, Szczech LA et al (2006) Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 1(3):518–524

    Article  PubMed  Google Scholar 

  18. Marr KA, Kong L, Fowler VG et al (1998) Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54:1694–1699

    Article  Google Scholar 

  19. Marr KA (2000) Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin Dial 13:23–29

    Article  PubMed  CAS  Google Scholar 

  20. Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191–1200

    Article  PubMed  CAS  Google Scholar 

  21. Parienti JJ, Thirion M, Mégarbane B et al (2008) Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 28:2413–2422

    Article  Google Scholar 

  22. Tanriover B, Carlton D, Saddekni S et al (2000) Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151–2155

    Article  PubMed  CAS  Google Scholar 

  23. Unver S, Atasoyu E, Evrenkaya TR, Ardic N, Ozyurt M (2006) Risk factors for the infections caused by temporary double-lumen hemodialysis catheters. Arch Med Res 37:348–352

    Article  PubMed  Google Scholar 

  24. Sanavi S, Ghods A, Afshar R (2007) Catheter associated infections in hemodialysis patients. Saudi J Kidney Dis Transpl 18:43–46

    PubMed  Google Scholar 

  25. Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC (2009) Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 76:1063–1069

    Article  PubMed  Google Scholar 

  26. Cappelli G, Tetta C, Canaud B (2005) Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant 20:266–270

    Article  PubMed  Google Scholar 

  27. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD (1995) Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 29:635–645

    Article  PubMed  CAS  Google Scholar 

  28. Marosok R, Washburn R, Indorf A, Solomon D, Sheretz R (1996) Contribution of vascular catheter material to the pathogenesis of infection: depletion of complement by silicone elastomer in vitro. J Biomed Mater Res 30:245–250

    Article  PubMed  CAS  Google Scholar 

  29. Lee H, Manns B, Taub K et al (2002) Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611–622

    Article  PubMed  Google Scholar 

  30. Manns B, Tonelli M, Yilmaz S et al (2005) Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 16:201–209

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriel Mircescu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ştefan, G., Stancu, S., Căpuşă, C. et al. Catheter-related infections in chronic hemodialysis: a clinical and economic perspective. Int Urol Nephrol 45, 817–823 (2013). https://doi.org/10.1007/s11255-012-0244-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0244-7

Keywords

Navigation